BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

568 related articles for article (PubMed ID: 23054123)

  • 21. American Society of Breast Surgeons MammoSite Radiation Therapy System Registry Trial: ductal carcinoma-in-situ subset analysis--4-year data in 194 treated lesions.
    Keisch M; Vicini F; Beitsch P; Quiet C; Keleher A; Garcia D; Snider H; Gittleman M; Zannis V; Kuerer H
    Am J Surg; 2009 Oct; 198(4):505-7. PubMed ID: 19800456
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Late side-effects and cosmetic results of accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: 5-year results of a randomised, controlled, phase 3 trial.
    Polgár C; Ott OJ; Hildebrandt G; Kauer-Dorner D; Knauerhase H; Major T; Lyczek J; Guinot JL; Dunst J; Miguelez CG; Slampa P; Allgäuer M; Lössl K; Polat B; Kovács G; Fischedick AR; Fietkau R; Resch A; Kulik A; Arribas L; Niehoff P; Guedea F; Schlamann A; Pötter R; Gall C; Uter W; Strnad V;
    Lancet Oncol; 2017 Feb; 18(2):259-268. PubMed ID: 28094198
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of treatment efficacy, cosmesis, and toxicity using the MammoSite breast brachytherapy catheter to deliver accelerated partial-breast irradiation: the william beaumont hospital experience.
    Chao KK; Vicini FA; Wallace M; Mitchell C; Chen P; Ghilezan M; Gilbert S; Kunzman J; Benitez P; Martinez A
    Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):32-40. PubMed ID: 17467920
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prospective multicenter trial evaluating balloon-catheter partial-breast irradiation for ductal carcinoma in situ.
    Abbott AM; Portschy PR; Lee C; Le CT; Han LK; Washington T; Kinney M; Bretzke M; Tuttle TM
    Int J Radiat Oncol Biol Phys; 2013 Nov; 87(3):494-8. PubMed ID: 24074922
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differences in patterns of failure in patients treated with accelerated partial breast irradiation versus whole-breast irradiation: a matched-pair analysis with 10-year follow-up.
    Antonucci JV; Wallace M; Goldstein NS; Kestin L; Chen P; Benitez P; Dekhne N; Martinez A; Vicini F
    Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):447-52. PubMed ID: 19058921
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical outcomes using accelerated partial breast irradiation in patients with invasive lobular carcinoma.
    Shah C; Wilkinson JB; Shaitelman S; Grills I; Wallace M; Mitchell C; Vicini F
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e547-51. PubMed ID: 21640491
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of survival and regional failure between accelerated partial breast irradiation and whole breast irradiation.
    Shah C; Wilkinson JB; Lyden M; Mbah A; Keisch M; Beitsch P; Vicini FA
    Brachytherapy; 2012; 11(4):311-5. PubMed ID: 22381652
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analyzing the risk of recurrence after mastectomy for DCIS: a new use for the USC/Van Nuys Prognostic Index.
    Kelley L; Silverstein M; Guerra L
    Ann Surg Oncol; 2011 Feb; 18(2):459-62. PubMed ID: 20859695
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Defining an optimal role for breast magnetic resonance imaging when evaluating patients otherwise eligible for accelerated partial breast irradiation.
    Horst KC; Fero KE; Ikeda DM; Daniel BL; Dirbas FM
    Radiother Oncol; 2013 Aug; 108(2):220-5. PubMed ID: 23597699
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Three-year analysis of treatment efficacy, cosmesis, and toxicity by the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial in patients treated with accelerated partial breast irradiation (APBI).
    Vicini F; Beitsch PD; Quiet CA; Keleher AJ; Garcia D; Snider HC; Gittleman MA; Zannis VJ; Kuerer HM; Lyden M
    Cancer; 2008 Feb; 112(4):758-66. PubMed ID: 18181095
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DCIS treated with excision alone using the National Comprehensive Cancer Network (NCCN) guidelines.
    Wehner P; Lagios MD; Silverstein MJ
    Ann Surg Oncol; 2013 Oct; 20(10):3175-9. PubMed ID: 23975306
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor bed control with balloon-based accelerated partial breast irradiation: incidence of true recurrences versus elsewhere failures in the American Society of Breast Surgery MammoSite(®) Registry Trial.
    Beitsch PD; Wilkinson JB; Vicini FA; Haffty B; Fine R; Whitworth P; Kuerer H; Zannis V; Lyden M
    Ann Surg Oncol; 2012 Oct; 19(10):3165-70. PubMed ID: 22836556
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radiation treatment for ductal carcinoma in situ (DCIS): is a boost to the tumor bed necessary?
    Yerushalmi R; Sulkes A; Mishaeli M; Neumann A; Dinerman M; Sulkes J; Rizel S; Yarom N; Gutman H; Fenig E
    Neoplasma; 2006; 53(6):507-10. PubMed ID: 17167720
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Accelerated partial breast irradiation using once-daily fractionation: analysis of 312 cases with four years median follow-up.
    Shaikh AY; LaCombe MA; Du H; Raghavan VT; Nanda RK; Bloomer WD
    Radiat Oncol; 2012 Feb; 7():17. PubMed ID: 22309790
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lumpectomy closure technique does not affect dosimetry in patients undergoing external-beam-based accelerated partial breast irradiation.
    Shaikh T; Narra V; Goyal S; Ahlawat S; Kirstein L; Kearney T; Haffty BG; Khan AJ
    Ann Surg Oncol; 2013 Apr; 20(4):1323-8. PubMed ID: 23229200
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Experience with partial breast irradiation for treatment of breast cancer at a community-based cancer center.
    Pasko J; Schray M; Lee M; Johnson N
    Am J Surg; 2014 May; 207(5):682-5; discussion 685. PubMed ID: 24791627
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trends in the use of implantable accelerated partial breast irradiation for ductal carcinoma in situ: Implications of the recent amendments to the American Society for Radiation Oncology consensus guidelines.
    Haque W; Verma V; Haque A; Butler EB; Teh BS
    Brachytherapy; 2017; 16(2):402-408. PubMed ID: 28063816
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of Outcomes in Patients With BRCA1/2 Breast Cancer Mutations Treated With Accelerated Partial Breast Irradiation (APBI).
    Ahmed F; Christos PJ; Singh P; Parashar B; Wernicke AG
    Am J Clin Oncol; 2019 May; 42(5):446-453. PubMed ID: 30973374
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcomes of breast cancer patients with triple negative receptor status treated with accelerated partial breast irradiation.
    Wilkinson JB; Reid RE; Shaitelman SF; Chen PY; Mitchell CK; Wallace MF; Marvin KS; Grills IS; Margolis JM; Vicini FA
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):e159-64. PubMed ID: 21345613
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost comparison of radiation treatment options after lumpectomy for breast cancer.
    Greenup RA; Camp MS; Taghian AG; Buckley J; Coopey SB; Gadd M; Hughes K; Specht M; Smith BL
    Ann Surg Oncol; 2012 Oct; 19(10):3275-81. PubMed ID: 22851048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.